rs226478
Positions:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001561.6(TNFRSF9):c.413+1116T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.767 in 152,288 control chromosomes in the GnomAD database, including 45,955 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.77 ( 45941 hom., cov: 33)
Exomes 𝑓: 0.80 ( 14 hom. )
Consequence
TNFRSF9
NM_001561.6 intron
NM_001561.6 intron
Scores
2
Splicing: ADA: 0.00001597
2
Clinical Significance
Conservation
PhyloP100: -2.00
Genes affected
TNFRSF9 (HGNC:11924): (TNF receptor superfamily member 9) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 1-7936574-A-G is Benign according to our data. Variant chr1-7936574-A-G is described in ClinVar as [Benign]. Clinvar id is 2688454.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNFRSF9 | NM_001561.6 | c.413+1116T>C | intron_variant | ENST00000377507.8 | |||
TNFRSF9 | XM_006710618.4 | c.413+1116T>C | intron_variant | ||||
TNFRSF9 | XM_047419672.1 | c.413+1116T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNFRSF9 | ENST00000377507.8 | c.413+1116T>C | intron_variant | 1 | NM_001561.6 | P1 | |||
TNFRSF9 | ENST00000492571.1 | c.180-11T>C | splice_polypyrimidine_tract_variant, intron_variant, NMD_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.767 AC: 116630AN: 152126Hom.: 45875 Cov.: 33
GnomAD3 genomes
AF:
AC:
116630
AN:
152126
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 1.00 AC: 8AN: 8Hom.: 4 AF XY: 1.00 AC XY: 2AN XY: 2
GnomAD3 exomes
AF:
AC:
8
AN:
8
Hom.:
AF XY:
AC XY:
2
AN XY:
2
Gnomad NFE exome
AF:
GnomAD4 exome AF: 0.795 AC: 35AN: 44Hom.: 14 Cov.: 0 AF XY: 0.813 AC XY: 26AN XY: 32
GnomAD4 exome
AF:
AC:
35
AN:
44
Hom.:
Cov.:
0
AF XY:
AC XY:
26
AN XY:
32
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.767 AC: 116756AN: 152244Hom.: 45941 Cov.: 33 AF XY: 0.770 AC XY: 57339AN XY: 74420
GnomAD4 genome
AF:
AC:
116756
AN:
152244
Hom.:
Cov.:
33
AF XY:
AC XY:
57339
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3132
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 94% of patients studied by a panel of primary immunodeficiencies. Number of patients: 83. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at